Thrombotic thrombocytopenic purpura: In a 38-year-old woman after taking a green tea supplement for weight loss (47)
PubMed laboratory research record [PMID: 27406927] PubMed record related to this compound for laboratory literature review
The cagrilintide and semaglutide combination (CagriSema) is the flagship application, and the clinical data confirms that the combination produces greater weight loss than either compound alone
Thus, this modest increase in LDL-C may be misleading regarding ASCVD risk, as patients with obesity may have a higher concentration of atherogenic small, dense LDL particles, and therefore high levels of apoB for a given blood LDL-C [10, 13]
There are a number of ways to prove a patient had their heart attack misdiagnosed, including: Show that a doctor in the same specialty or in a similar specialty would not have misdiagnosed those signs of illness
However, this doesnt mean that the studies establish a direct cause-and-effect relationship